Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jul '25 Jul 31, 2025	Jan '13 Jan 31, 2013	Jan '12 Jan 31, 2012	Jan '11 Jan 31, 2011	Jan '10 Jan 31, 2010	Jan '09 Jan 31, 2009
Market Capitalization	1	8	-	-	-	-
Enterprise Value	-	8	-	-	-	-
Last Close Price	0.00	0.06	-	-	-	-
PB Ratio	-2.10	-62.64	-	-	-	-
Debt / Equity Ratio	-0.56	-0.33	-0.60	0.54	3.23	-1.00
Quick Ratio	-	-	-	0.94	1.05	-
Current Ratio	0.00	-	-	1.83	1.05	-
Return on Equity (ROE)	-	-	-	-542.58%	-	-
Return on Assets (ROA)	-1370.88%	-	-	-92.15%	-	-
Return on Capital (ROIC)	-	-	-485.14%	-165.70%	-556.91%	-
Earnings Yield	-42.12%	-1.41%	-	-	-	-
Buyback Yield / Dilution	64.17%	40.59%	-15.66%	-2873.84%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.